Suven Life Sciences Balance Sheet Annual

Trade

BSE: 530239 | NSE: SUVEN | ISIN: INE495B01038 | Sector: Biotechnology & Drugs

118.50 +1.05 (0.89%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	14.93	12.02	5.27	9.35
Cash Equivalents	149.05	25.00	0.00	36.92
Short Term Investments	75.94	191.41	45.16	0.09
Cashand Short Term Investments	239.91	228.43	50.44	46.35
Accounts Receivable- Trade Net	1.29	0.81	1.30	1.76
Total Receivables Net	5.28	20.61	14.71	55.39
Total Inventory	0.71	0.00	0.02	0.14
Other Current Assets Total	10.77	2.19	1.00	0.38
Total Current Assets	256.67	251.59	66.59	102.68
Property/ Plant/ Equipment Total- Net	28.01	37.02	40.89	25.60
Intangibles Net	0.20	0.20	0.22	0.14
Long Term Investments	0.02	100.00	-	-
Other Long Term Assets Total	0.01	0.02	-	-
Total Assets	284.90	388.91	108.03	128.42
Accounts Payable	2.07	1.66	1.99	3.00
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	0.71	1.03	1.64	2.05
Other Currentliabilities Total	10.74	8.44	4.69	10.87
Total Current Liabilities	13.52	11.13	8.31	15.91
Capital Lease Obligations	0.00	0.58	1.57	2.33
Total Long Term Debt	0.00	0.58	1.57	2.72
Total Debt	0.71	1.61	3.21	4.76
Other Liabilities Total	1.35	1.88	2.00	1.78
Total Liabilities	14.86	13.59	11.89	20.41
Common Stock Total	21.81	21.81	14.54	12.73
Retained Earnings( Accumulated Deficit)	248.23	-291.37	-173.29	-14.23
Total Equity	270.04	375.32	96.15	108.01
Total Liabilities Shareholders' Equity	284.90	388.91	108.03	128.42
Total Common Shares Outstanding	21.81	21.81	15.78	13.82
Tangible Book Valueper Share Common Eq	12.37	17.20	6.08	7.81
Prepaid Expenses	-	0.36	0.43	0.41
Property/ Plant/ Equipment Total- Gross	-	88.59	82.31	66.80
Accumulated Depreciation Total	-	-51.57	-44.97	-45.97
Note Receivable- Long Term	-	0.09	0.33	0.00
Additional Paid- In Capital	-	646.78	256.65	110.81
Other Equity Total	-	-1.90	-1.75	-1.31
Long Term Debt	-	-	0.00	0.39
Deferred Income Tax	-	-	0.00	0.00